Skip to main content
search

Early Clinical

Sign up

Latest resources

Featured resource

Upcoming early clinical webinars

Latest early clinical blogs

Meet our experts at the following events

Live Events

Phoenix Roadshow 2026 – Florence

March 26, 2026
Live Events

Certara IQ™ Global Roadshow

Certara IQ™ is going on the road. From APAC to Europe to North America, our experts are bringing hands-on, indepth
Conference

Quantitative Systems Pharmacology Conference

April 8 - 10, 2026

All early clinical resources

Right Dose, Right Regimen: Model-Informed Strategies for Antibody–Drug Conjugates (ADCs)

ADC, Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, On-Demand Webinar

Why the Most Important Phase 3 Decisions Should Be Made Before Phase 3

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - QSP, Blog

Building Smarter Trials With Bayesian Statistics

Certara Services, Press Coverage, Video

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis

Certara Products - Phoenix, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Publication

Model-informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis

Biologics, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Regulatory horizons 2026: clinical pharmacology strategy and regulatory expectations

Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, New Approach Methodologies (NAMs), Blog

How to Improve CRO Data Management

Certara Products - Pinnacle 21, Fact Sheet

Leveraging the full potential of PBPK models to accelerate drug development

Certara Products - Simcyp, Modeling and Simulation - PBPK, On-Demand Webinar

Pharmacometrics Under Pressure

Certara Products - Phoenix, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Webinar

What are Common Bioequivalence Study Mistakes?

Certara Products - Phoenix, Certara Products - Simcyp, Blog

Rethinking Trial Design With Bayesian Approaches

Certara Services, Press Coverage, Video

ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug Development

Certara Products - Simcyp, Modeling and Simulation, Modeling and Simulation - PBPK, Pharmacometrics, Blog
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.